Savara
SVRA
#6222
Rank
C$1.51 B
Marketcap
C$7.36
Share price
-3.64%
Change (1 day)
62.64%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -C$0.18 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.17 Billion a decrease over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.18 Billion8%
2025 -C$0.17 Billion23.94%
2024 -C$0.14 Billion75.29%
2023 -C$76.08 Million43.38%
2022 -C$53.07 Million-11.31%
2021 -C$59.83 Million-13.3%
2020 -C$69.01 Million-36.53%
2019 -C$0.11 Billion13.76%
2018 -C$95.58 Million105.54%
2017 -C$46.5 Million34.11%
2016 -C$34.68 Million-37.43%
2015 -C$55.42 Million38.81%
2014 -C$39.92 Million33.62%
2013 -C$29.88 Million38.49%
2012 -C$21.58 Million24.59%
2011 -C$17.32 Million-36.5%
2010 -C$27.27 Million-3.14%
2009 -C$28.16 Million-23.28%
2008 -C$36.7 Million8.52%
2007 -C$33.82 Million-34.14%
2006 -C$51.35 Million184.43%
2005 -C$18.06 Million90.75%
2004 -C$9.47 Million190.35%
2003 -C$3.26 Million11.64%
2002 -C$2.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.32 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.26 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA